Xao Tam Phan (Paramignya trimera) methanol extract induced apoptosis in hepatocellular carcinoma HepG2 cell line in vitro

Science & Technology Development Journal, 23(1):484-489 Open Access Full Text Article Original Research 1Stem Cell Institute, University of Science Ho Chi Minh City, Viet Nam 2Cancer Research Laboratory, University of Science Ho Chi Minh City, Viet Nam 3Viet Nam National University Ho Chi Minh City, Viet Nam 4Medical Genetic Institute, Ho Chi Minh City, Viet Nam 5Laboratory of Stem Cell Research and Application, University of Science Ho Chi Minh City, Viet Nam Correspondence Phuc Van Pham, Stem Cell Institute, University of Science Ho Chi Minh City, Viet Nam Cancer Research Laboratory, University of Science Ho Chi Minh City, Viet Nam Viet Nam National University Ho Chi Minh City, Viet Nam Laboratory of Stem Cell Research and Application, University of Science Ho Chi Minh City, Viet Nam Email: pvphuc@hcmuns.edu.vn; phucpham@sci.edu.vn Xao Tam Phan (Paramignya trimera) methanol extract induced apoptosis in hepatocellular carcinoma HepG2 cell line in vitro Sinh Truong Nguyen1,2,3, Nghia Minh Do1,2,3, Phuc Vo Hong1,2,3, Trinh Thi – Tu Nguyen1,3, Kiet Dinh Truong4, Phuc Van Pham1,2,3,5,* Use your smartphone to scan this QR code and download this article ABSTRACT Introduction: Xao Tam Phan (Paramignya trimera) has long been used in Viet Nam as an herbal medicine for the treatment of Hepatitis, hepatocellular carcinoma, and diabetes. This study aimed to determine the anti-proliferation effect of Paramignya trimera extract (P. trimera extract) on HepG2 hepatocellular carcinoma cells. Methods: AlamarBlue assay was used to determine the IC50 val- ues of P. trimera extract on HepG2 cells. Adipose-derived stem cells (ADSCs) was used as normal cell control. For apoptosis examination, P. trimera extract-treated HepG2 cells were incubated with Annexin V/Propidium iodide (PI). Then they have been analyzed their expression of Annexin-V and PI by flow cytometry. The cell nuclear degradation also was evaluated by PI/Hoechst 33342 stain- ing assay. Results: Doxorubicin and P. trimera extract IC50 values on HepG2 cells were 55.13  2.028 ng/ml and 582.533  16.521 mg/ml, respectively. Those on ADSCs were 5.96  0.56 ng/ml and 268.976  19.325 mg/ml, respectively. Side effect index value (SEI) of P. trimera extract was 2.175  0.12, and the SEI of doxorubicin was 8.71  0.36. Flow cytometry analysis indicated sig- nificant apoptosis on P. trimera extract-treated HepG2 cells at a dose of 500 mg/ml (32.39 2.28% apoptotic cells, and 14.63 1.59% necrotic cells). Nuclear aggregation and degradation was seen on 500 mg/ml P. trimera treated HepG2 cells. Conclusion: P. trimera extract could inhibit HepG2 hepatocellular carcinoma cell proliferation by inducing apoptosis. Key words: Paramignya trimera, HepG2, side index effect, apoptosis, flow cytometry INTRODUCTION According to Globcan 2018 statistics, 841.080 people were diagnosed with liver cancer worldwide; an esti- mated 781,631 people died from the disease 1. Among the most common types of fatal cancer in the world, liver cancer has the fourth highest mortality rate and accounts for the second-highest death rate for men2. Among the regions, Asia is the most alarming region. Asia has consistently led the way in terms of new cases of diagnosis andmortality, as well as the proportion of people living with liver cancer. The highest is in West Asia and then Southeast Asia 1. According to IARC data in 2018, Viet Nam had 25335 new cases, 25404 deaths, and 21055 people living for five years with liver cancer3. Liver cancer accounts for the highest percentage of all common diseases, as well as the leading cause of death in Viet Nam. There have been many developed methods to treat cancer. Among them, five routine methods are commonly used: tumor removal surgery, chemotherapy, radi- ation therapy, hormone therapy, and immunother- apy4. Depending on the type of cancer, the patient’s condition that the doctor chooses a suitable treatment or a combination of treatments to bring the best effect. In particular, chemotherapy is still an important method to treat this disease. However, the cases of drug resistance are getting a problem. Besides, chemotherapy also causes many side effects, the pos- sibility of cancer recurrence. Research on developing new drugs is still being promoted, including the use of compounds derived from nature, especially medic- inal plants from ancient times. Up to date, folk reme- dies still play an essential role in the treatment and protection of human health. Vinca alkaloid, saponins, flavonoids, and their derivatives are anti-cancer com- pounds isolated from plants and scientifically proven to treat cancer5–7. Vietnam is located in the tropics, with abundant bio- logical resources, including many herbs that, accord- ing to folk medicine points, can cure cancer. How- ever, most are used according to folk experience or used as a functional food, without precisemechanism. In Vietnam and Thailand, P. trimera extract is con- sidered a folk medicine to treat hepatitis, liver cancer, and diabetes8. However, studies on P. trimera in gen- eral and their medicinal properties are quite limited. Xao Tam Phan is a small tree with a climbing body; body more than 4 m long, about 10 cm diameter; Cite this article : Truong Nguyen S, Minh Do N, Vo Hong P, Thi – Tu Nguyen T, Dinh Truong K, Van Pham P. Xao Tam Phan (Paramignya trimera) methanol extract induced apoptosis in hepatocellular carci- noma HepG2 cell line in vitro. Sci. Tech. Dev. J.; 23(1):484-489. 484 History  Received: 15 Dec 2019  Accepted: 03 Mar 2020  Published: 31 Mar 2020 DOI : 10.32508/stdj.v23i1.2013 Copyright © VNU-HCM Press. This is an open- access article distributed under the terms of the Creative Commons Attribution 4.0 International license. Science & Technology Development Journal, 23(1):484-489 body and branches hairless, spiky, and to 7 to 8 cm long, slightly curved down. Leaves grow in a cluster or three-fold pattern; thick slab; oblong to extended narrow circles; size 10 – 18 x 1 – 2.5 cm; The whole cover is slightly bent; tendon filler 8 – 10 pairs; peti- oles short, 2 - 3 mm long. The parts of the plant have the essential oils, and their roots are at most8. In Vietnam, the P. trimera tree grows mainly in tropi- cal forests, especially in the central provinces such as Khanh Hoa, Ninh Thuan, and Binh Thuan, in addi- tion to areas adjacent to Laos and Cambodia. According to folk experience, P. trimera roots are used as medicine. P. trimera root has a slightly bitter taste, slightly acrid, slightly sweet. According to some ana- lyzes, P. trimera extract contains saponin (267.15 mg EE/g dry sample), proanthocyanidin (3.98 mg CE/g dry sample), phenolic (11.27 mg GAE/g dry sam- ple), flavonoid (19.88 mg RE/g dry sample)9. Be- sides, P. trimera extract has also been shown to con- tain coumarins with potent anti-inflammatory prop- erties, including ostruthin and ninhvanin10. More- over, there are also studies proving P. trimera has many antioxidants. In another recent study, it was shown that P. trimera extract has a strong ability to inhibit MCF-7 breast cancer cells in both 2D and 3D culture conditions11. However, there have not been many studies on the anti-proliferation of this plant on HepG2 hepatocel- lular carcinoma cells. Therefore, this study aimed to assess the effects of P. trimera extract on HepG2 hep- atocellular carcinoma cells. MATERIAL—METHODS Cell culture HepG2 hepatocellular carcinoma cells were obtained from ATCC (Manassas, VA). They were cultured in DMEM/F12 medium (Thermo Fisher Scientific, Waltham, MA) containing 10% fetal bovine serum (FBS) and 1% antibiotic-mycotic (Gibco, Thermo Fisher Scientific, MA). HepG2 cells were cultured at 5% CO2 humidified atmosphere at 37oC. Cells were passed at 80% confluency by trypsin/EDTA (0.025%) (Gibco, Thermo Fisher Scientific, MA). Adipose-derived stem cells (ADSCs) were isolated from adipose tissues with consent from the donor as the published protocol12. Adipose tissues were kept in cool temperature in PBS solution containing 1% antibiotic-antimycotic solution, and transferred to the laboratory for subsequent processing. The stromal vascular fraction (SVF) was extracted from the adi- pose tissue by the Cell Extraction Kit (Regenmedlab, Ho Chi Minh City, VN). Then SVF was cultured to collect ADSCs per a previously published protocol. All assays were performed per the published study12. Cytotoxicity assay HepG2 and ADSC cells were seeded in 96 wells plate. The cell density was 2500 cells per well. After 24h, cells were treated with P. trimera extract at concen- tration 2000, 1000, 500, 250, 125, 60,30,15,7 mg/ml. Parallelly, HepG2 cells also treated with doxorubicin at concentrations of 2000, 1000, 500, 250, 125, 60, 30, 15,7 ng/ml. After 48h incubation, cells were evaluated viability by Alamar Blue assay. Side Effect Index (SEI) is calculated using the formula: SEI P. trimera = IC50 o f P:trimera extract on HepG2 cellsIC50 o f P:trimera extract on ADSCs SEI Doxorubicin = IC50 o f Doxorubicin HepG2 cellsIC50 o f Doxorubin on ADSCs Apoptosis assay HepG2 cells were seeded in 6 wells plate. The cell den- sity was 200.000 cells per well. Cells were treated with P. trimera extract at concentrations of 60, 125, 250, 500, and 1000 mg/ml and incubated in 48h. Cells were labeled with 3 mL Annexin V-FITC (BD Biosciences, Franklin Lakes, NJ) (and 3 m l of Propodium Iodide (PI) in 500 m l of binding buffer for 15 mins to de- tect apoptotic and necrotic cell death using a FAC- SCalibur FlowCytometer. Data were analyzed by Cel- lquest software (BD Biosciences). Nuclei staining assay HepG2 cells were added into a 6-well plate with a den- sity of 200000 cells/well. HepG2 cells were treated with P. trimera extract at concentrations of 2000 mg/ml, 500 mg/ml, 125 mg/ml, and control for 48 hours. Similarly, doxorubicin was added at concen- trations of 300 ng/ml, 60 ng/ml, 15 ng/ml, and control for 48 hours. Then, cells mixed with 50 ml Hoechst 33342 and 10 ml Propidium Iodide, incubated for 10 minutes. Finally, the cell suspension was dropped in the lame, observed under the microscope fluores- cence objective 40X (Carl-Zeiss, Germany). RESULTS Cytotoxicity of P. trimera extract and dox- orubicin on HepG2 cells The results showed that IC50 values of P. trimera extract on ADSCs and HepG2 cells were 268.98  19.33 mg/ml and 582.53  16.52 mg/ml, respectively (Figure 1). The IC50 values of doxorubicin on ADSCs and HepG2 cells are 5.96  0.56 ng/ml and 55.13  2.028 ng/ml, respectively. We performed the side ef- fects index (SEI) of P. trimera and doxorubicin. SEI is considered as a method to assess the toxicity of a sub- stance on a normal cell line. The result showed that SEI value of P. trimerawas 2.175 0.12, and SEI value of doxorubicin was 8.71 0.36. 485 Science & Technology Development Journal, 23(1):484-489 Figure 1: Anti-proliferation of P. trimera extract and doxorubicin on HepG2 cells and ADSCs. Cells were seeded into 96-well plates for 24 hours. Cells were then treated with P. trimera extract at concentrations 2000, 1000, 500, 250, 125, 60, 30, 15, 7 mg/ml. Parallelly, cells also treated with doxorubicin at the concentration 2000, 1000, 500, 250, 125, 60, 30, 15, 7 ng/ml. After 48 hours, cell viability was measured with dye Alamar Blue assay. A. Cell proliferation curve of HepG2 cells and ADSCs when treated with P. trimera extract. B. Cell proliferation curve of HepG2 cells and ADSCs when treated with doxorubicin. C. Comparison of SEIs between P. trimera extract and Doxorubicin on HepG2 cells and ADSCs. **** P<0.0001. The experiment was triplicated. Apoptosis of HepG2 cells after treatment of P. trimera extract Results showed that the total percentage of late apop- tosis increased in dose-dependent manner. Late apoptosis population at concentrations of P. trimera extract 60, 125, 250, 500, 1000 mg/ml increased by 6.687  0.78%, 7.28  0.85%, 9.77  1.35%, 7.743  2.67%, 32.82 2.28%, 49.28  2.43% respectively (Figure 2). At the concentration of 500 mg/ml, the total cell death counted almost 50%. When the con- centration increased up to 1000 mg/ml, cell death was at 80%. This result proves that P. trimera extract can induce apoptosis in HepG2 cells. Cell nuclei fragmentation of HepG2 cells af- ter treatment of P. trimera and doxorubicin extracts PI and Hoechst 33342 staining results showed in both P. trimera extract treatment group, and doxorubicin treatment group, the number of dead cells increased in the manner of concentration dependence. These cells have DNA compressed or fragmented. In con- trol, cells were mainly in blue fluorescent with contact cell nuclei. When cells were treated with P. trimera extract at the concentration of IC50 value and at 1/4 of IC50 value, dead cells were significantly increased compared to that in control (582.533 16.521 mg/ml) at IC50, and 49.33  2.50% at 14 of IC50 compared to 7.00  1.00% at control). Particularly, when cells were treated with P. trimera extract at 4 x IC50 con- centration, most cells were no longer intact (94.00  6.25%), stained with red fluorescent (Figure 3). This result proves that P. trimera extract can cause HepG2 cell death and nuclear fragmentation. DISCUSSION According to the World Cancer Research Organiza- tion (IARC), Vietnam is in an epidemiological area with a high rate of liver cancer. In 2018, liver cancer led to the number of new cases anddeaths in the coun- try. Studies looking for extracts or compounds to 486 Science & Technology Development Journal, 23(1):484-489 Figure 2: Apoptosis population of HepG2 after treatment with P. trimera extract. HepG2 cells were treated with P. trimera extract at concentrations of 60, 125, 250, 500 and 1000 mg/ml. After 48 hours, cells were stained with Annexin V and PI and analyzed with FACSCalibur flow cytomtter. Figure 3: DNA fragmentation of HepG2 cells (magnification at X40). HepG2 cells were treated with P. trimera extract at concentrations of 4 x IC50 (2000 mg/ml), IC50 (500 mg/ml), 14 IC50 (125 mg/ml), and control. Similarly, doxorubicin was treated at concentrations of 4 x IC50 (300 ng/ml), IC50 (60 ng/ml), 14 IC50 (15 ng/ml), and control. After 48 hours of treatment, cells were stained with Hoechst 33342 and PI dyes. Cells were then observed under ImageXpress Micro Confocal microscope. Cells underwent apoptosis have a nucleus of DNA that compresses and fragments, indicated by white arrow. The red cells at doxorubicin 4 x IC50 (300 ng/ml); IC50 (60 ng/ml); 14 IC50 (15 ng/ml); control is 61  3.6%; 46 2%; 17 1%; 13.3 31.53%. The red cells at P. trimera IC50 (2000 mg/ml); IC50 (500 mg/ml); 14 IC50 (125 mg/ml); control is 94 6.25%; 49.33 2.52%; 7 1%; 3 1%, respectively. 487 Science & Technology Development Journal, 23(1):484-489 treat the disease are always promoted13. About 80% of cancer medicines approved by the US Food and Drug Administration (FDA) are derived from natu- ral compounds, mainly from medicinal plants14. The rich and diverse biological resource of Vietnam is an abundant source of medicinal materials. There are many types of plants used as medicines. However, there is no scientific evidence of a transparent effect. Among them, Xao tam phan (P. trimera) is a plant be- longing to the Citrus family (Rutaceae). In our pre- vious study, P. trimera extract showed a strong in- hibitory effect on MCF-7 breast cancer cell lines in 2D culture conditions (260.8  16.54 mg/ml) and 3D (IC50 168.9  11.65 mg/ml). It was shown that P. trimera has a full inhibitory effect on the invasion of MCF-7 cells14. To clarify the impact of P. trimera ex- tract on liver carcinoma line, we conducted a test to determine the impact of this extract on HepG2 cells. The IC50 value of P. trimera extract was established on two lines of HepG2 cells and ADSCs, and dox- orubicin used as a positive agent. The results showed that the average IC50 values of P. trimera and doxoru- bicin on HepG2 cells were 582.53  16.52 ng/ml and 55.13  2.03 ng/ml. For ADSCs, P. trimera extract had an average IC50 value of 268.98  19.33 mg/ml. The IC50 value of doxorubicin on ADSCs was 5.96  0.56 ng/ml. Besides, the side effects index SEI values of P. trimera and doxorubicin were 2.175  0.12 and 8.71  0.36. This result proves that in addition to the inhibitory effect on the MCF-7 cell line published in the previous study 11, P. trimera extract also has anti- proliferation effects on the HepG2 cells and P. trimera has less side effects than doxorubicin. This could be a promising potential for cancer treatment. Doxorubicin is one of themost commonly used drugs in cancer chemotherapy. The study showed that doxorubicin was removed from the body by reduc- ing two electrons by carbonyl reductase, which is most important in the liver15. Doxorubicin resis- tance is also due to over-expression of the adenosine triphosphate-binding cassette (ABC) family, typically ABCB1 (MDR1; MDR1) or ABCC1 (MDR1-related gene 1; MRP1)16,17. These may be the cause of higher IC50 in HepG2 than those in ADSC. Apoptosis is an important process for getting rid of cells that lose function in the body. Cancer cells, though not functioning, still exist due to their ability to evade programmatic death. The anticancer drug, therefore, aims to resist cell division or kill cancer cells through apoptosis or necrosis18. Flow cytom- etry result showed that after treatment of P. trimera extract, apoptosis population cells increased by 6.687  0.78%, 7.28  0.85%, 9.77  1.35%, 7.74  2.67%, 32.82  2.28%, 49.28  2.43% correspond to con- centrations of 60, 125, 250, 500 and 1000 mg/ml. In which the concentration of 500 mg/ml showed a sig- nificant increase in cyclic cell death rate (31%). This result showed that P. trimera can activate the pro- grammed pathway of death. Nuclear fragmentation, an important feature of programmed cell death, is bio- logical damage at the molecular biology level. Results showed that cells treated with P. trimera have nuclei compressed, divided into small pieces, the cell mem- brane remains intact. This result provides further ev- idence that P. trimera extract has the ability to inhibit HepG2 cells through the programmed cell death. CONCLUSION Cancer is the leading cause of death worldwide. Live cancer is high rate of death in Vietnam. Traditional medicine plays the critical role in drug development. Vietnam possesses tropical forest with resources of potential herbal medicine. P.trimera is popularly used in primarily treatment of some disease. In this study, P. trimera has shown that it can anti-proliferate HepG2 cells at IC50 268.98  19.33 mg/ml, while P. trimera has less side effect on ADSCs compared to doxorubicin. This implicated that P. trimera is the po- tential herbal in further investigation of drug develop- ment for cancer. ABBREVIATIONS ADSC: adipose-derived stem cell P. trimera: Paramignya trimera SEI: side effects index COMPETING INTERESTS All authors equally contributed in this work. All authors read and approved the final version of the manuscript for submission. AUTHORS’ CONTRIBUTIONS Theauthors report no conflicts of interest in thiswork. ACKNOWLEDGMENTS This work was supported by the Vietnam National University, Ho Chi Minh City, Vietnam, under grant A2015-18-01. 488 Science & Technology Development Journal, 23(1):484-489 REFERENCES 1. 11 liver fact sheet [ ncers/11-Liver-fact-sheet.pdf]. 2. Facts in pictures/Detail/Cancer [https://www.who.int/news-r oom/facts-in-pictures/detail/cancer]. 3. 704 Vietnam fact sheet [ ets/populations/704-viet-nam-fact-sheets.pdf]. 4. Sudhaka A. History of cancer, ancient and modern treatment methods. Journal of cancer science & therapy. 2009;1(2):1. PMID: 20740081. Available from: https://doi.org/10.4172/ 1948-5956.100000e2. 5. Man S, Gao W, Zhang Y, L H, C L. Chemical study and med- ical application of saponins as anti-cancer agents. Fitoter- apia. 2010;81(7):703–714. PMID: 20550961. Available from: https://doi.org/10.1016/j.fitote.2010.06.004. 6. Batra P, Sharma AK. Anti-cancer potential of flavonoids: re- cent trends and future perspectives. 3 Biotech. 2013;3(6):439– 459. PMID: 28324424. Available from: https://doi.org/10.1007/ s13205-013-0117-5. 7. Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. Journal of natural products. 2016;79(3):629–661. PMID: 26852623. Available from: https: //doi.org/10.1021/acs.jnatprod.5b01055. 8. Hộ PH: Cây cỏ Việt Nam, tập 1, 2, 3. Nxb trẻ, Thành phố Hồ Chí Minh 1999. 9. Nguyen T, Pham NMQ, Vuong Q, Bowyer M, van Altena I A, Scarlett C. Phytochemical retention and antioxidant ca- pacity of Xao tam phan ( Paramignya trimera ) root as pre- pared by different drying methods. Drying Technology. 2015;34(3):324–334. Available from: https://doi.org/10.1080/ 07373937.2015.1053566. 10. HL TA, D-C K, W K, TM H, NX N, PH Y, et al. Anti- inflammatory coumarins from Paramignya trimera. Pharm Biol. 2017;55(1):1195–1201. PMID: 28245363. Available from: https://doi.org/10.1080/13880209.2017.1296001. 11. Nguyen-Thi LH, Nguyen ST, Tran T, Phan-Lu CN, Van TT, Pham PV. Anti-cancer Effect of Xao Tam Phan Paramignya trimera Methanol Root Extract onHumanBreastCancerCell LineMCF- 7 in 3D Model. Advances in experimental medicine and biol- ogy . 2018;2018([First Online]). Available from: https://doi.org/ 10.1007/5584_2018_148. 12. P P, NB V, NL-C P, DM L, NC T, NH T, et al. Good manufac- turing practice-compliant isolation and culture of human adi- pose derived stem cells. Biomedical Research and Therapy. 2014;4(1):1–9. Available from: https://doi.org/10.7603/s40730- 014-0021-6. 13. Saxena M, Saxena J, Nema R, Singh D, Gupta A. Phytochem- istry of medicinal plants. Journal of pharmacognosy and phy- tochemistry. 2013;1(6). 14. DJ N, GM C. Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of natural products. 2012;75(3):311–335. PMID: 22316239. Available from: https: //doi.org/10.1021/np200906s. 15. N K, K H, H-J M, U GA, A M, I M, et al. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metabolism and Disposition. 2008;36(10):2113–2120. PMID: 18635746. Available from: https://doi.org/10.1124/dmd.108. 022251. 16. G L, X C, Q W, Z X, W Z, L Y. The roles of four multi-drug re- sistance proteins in hepatocellular carcinoma multidrug re- sistance. Journal of Huazhong University of Science and Technology;27(2):173–175. PMID: 17497289. Available from: https://doi.org/10.1007/s11596-007-0217-8. 17. J W, JYW C, CC F, CH T, KP F, M Y. Transcriptional analy- sis of doxorubicin-induced cytotoxicity and resistance in hu- man hepatocellular carcinoma cell lines. Liver International. 2009;29(9):1338–1347. PMID: 19627484. Available from: https://doi.org/10.1111/j.1478-3231.2009.02081.x. 18. Mahassni SH, Al-Reemi RM. Apoptosis and necrosis of hu- man breast cancer cells by an aqueous extract of garden cress (Lepidium sativum) seeds. Saudi journal of biological sci- ences. 2013;20(2):131–139. PMID: 23961228. Available from: https://doi.org/10.1016/j.sjbs.2012.12.002. 489